Geode Capital Management
XFOR icon

Geode Capital Management’s X4 Pharmaceuticals XFOR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$93.4K Sell
49,146
-3,570,536
-99% -$6.79M ﹤0.01% 4074
2025
Q1
$856K Buy
3,619,682
+122,470
+4% +$29K ﹤0.01% 3356
2024
Q4
$2.57M Buy
3,497,212
+49,700
+1% +$36.5K ﹤0.01% 3045
2024
Q3
$2.31M Sell
3,447,512
-68,026
-2% -$45.5K ﹤0.01% 3077
2024
Q2
$2.04M Buy
3,515,538
+570,114
+19% +$331K ﹤0.01% 3123
2024
Q1
$4.09M Buy
2,945,424
+142,975
+5% +$199K ﹤0.01% 2805
2023
Q4
$2.35M Buy
2,802,449
+159,534
+6% +$134K ﹤0.01% 3040
2023
Q3
$2.88M Buy
2,642,915
+292,705
+12% +$319K ﹤0.01% 2923
2023
Q2
$4.56M Buy
2,350,210
+1,241,526
+112% +$2.41M ﹤0.01% 2730
2023
Q1
$965K Buy
1,108,684
+521,168
+89% +$453K ﹤0.01% 3365
2022
Q4
$583K Buy
587,516
+93,859
+19% +$93.1K ﹤0.01% 3593
2022
Q3
$844K Buy
493,657
+304,109
+160% +$520K ﹤0.01% 3481
2022
Q2
$182K Buy
189,548
+6,271
+3% +$6.02K ﹤0.01% 4328
2022
Q1
$320K Buy
183,277
+5,217
+3% +$9.11K ﹤0.01% 4153
2021
Q4
$407K Hold
178,060
﹤0.01% 4153
2021
Q3
$941K Buy
178,060
+16,143
+10% +$85.3K ﹤0.01% 3713
2021
Q2
$1.05M Sell
161,917
-96,248
-37% -$625K ﹤0.01% 3565
2021
Q1
$2.22M Buy
258,165
+1,711
+0.7% +$14.7K ﹤0.01% 3210
2020
Q4
$1.65M Buy
256,454
+13,466
+6% +$86.5K ﹤0.01% 3181
2020
Q3
$1.65M Buy
242,988
+15,016
+7% +$102K ﹤0.01% 2976
2020
Q2
$2.12M Buy
227,972
+18,553
+9% +$173K ﹤0.01% 2804
2020
Q1
$2.09M Buy
209,419
+28,498
+16% +$285K ﹤0.01% 2648
2019
Q4
$1.94M Buy
180,921
+66,389
+58% +$710K ﹤0.01% 3021
2019
Q3
$1.46M Buy
114,532
+451
+0.4% +$5.73K ﹤0.01% 3089
2019
Q2
$1.71M Buy
114,081
+101,179
+784% +$1.52M ﹤0.01% 3043
2019
Q1
$224K Sell
12,902
-53,237
-80% -$924K ﹤0.01% 3702
2018
Q4
$153K Buy
66,139
+21,111
+47% +$48.8K ﹤0.01% 3746
2018
Q3
$72K Buy
45,028
+4,949
+12% +$7.91K ﹤0.01% 3982
2018
Q2
$145K Buy
40,079
+8,213
+26% +$29.7K ﹤0.01% 3797
2018
Q1
$729K Buy
+31,866
New +$729K ﹤0.01% 3267